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b-lactam antibiotics inhibit bacterial cell wall assem-
bly and, under classical microbiological culture
conditions that are generally hypotonic, induce
explosive cell death. Here, we show that under
more physiological, osmoprotective conditions, for
various Gram-positive bacteria, lysis is delayed or
abolished, apparently because inhibition of class A
penicillin-binding protein leads to a block in autolytic
activity. Although these cells still then die by other
mechanisms, exogenous lytic enzymes, such as
lysozyme, can rescue viability by enabling the
escape of cell wall-deficient ‘‘L-form’’ bacteria. This
protective L-form conversion was also observed in
macrophages and in an animal model, presumably
due to the production of host lytic activities,
including lysozyme. Our results demonstrate the po-
tential for L-form switching in the host environment
and highlight the unexpected effects of innate im-
mune effectors, such as lysozyme, on antibiotic
activity. Unlike previously described dormant per-
sisters, L-forms can continue to proliferate in the
presence of antibiotic.
INTRODUCTION
The cell wall is one of the defining structures of bacterial cells,
and the main component is a normally essential polymer called
peptidoglycan (PG) (Ho¨ltje, 1998; Typas et al., 2011). The PG
precursor molecule, called lipid II, is made in the cytosol via a
well conserved biochemical pathway, then transferred to the
outside of the cytoplasmic membrane, where it is assembled
by glycosyltransferase (GTase) and transpeptidase (TPase) en-
zymes (Figure 1A). The key TPases are called penicillin-binding
proteins (PBPs) because they are targeted by penicillin and other
b-lactam antibiotics (Lovering et al., 2012). b-lactams are one of
the oldest and still most widely used antibiotics. They prevent
cell wall assembly and it is generally considered that this kills
bacteria by explosive cell lysis. However, classical microbiolog-
ical culture conditions are mainly hypotonic and under osmopro-
tective (isotonic) conditions lysis is largely suppressed, although
the cells are prevented from growing and die, possibly through1038 Cell 172, 1038–1049, February 22, 2018 ª 2018 The Authors. P
This is an open access article under the CC BY license (http://creativeother mechanisms such as oxidative damage (Dwyer et al.,
2015; Kawai et al., 2015) or futile cycling of the cell wall precursor
pathway (Cho et al., 2014).
In light of the importance of the wall, it is surprising that many
bacteria are able to switch into a wall-deficient state called
the L-form (Klieneberger, 1935), which is completely resistant
to most antibiotics working specifically on cell wall synthesis,
particularly b-lactams. Most classically described L-forms
were observed in samples obtained from humans, animals,
and plants and also identified as antibiotic resistant organisms
isolated in association with a wide range of infectious diseases
(Allan et al., 2009; Domingue and Woody, 1997; Errington
et al., 2016). However, their possible role in chronic or recurrent
infections remains controversial. Crucially, the molecular events
underlying switching to and from the L-form state in the host
environment are presently unclear.
The Gram-positive bacterium Bacillus subtilis has been re-
ported to switch into the L-form state under laboratory condi-
tions (Leaver et al., 2009), as well as in plants (Ferguson
et al., 2000). We have recently developed a tractable system
for studying the cell biology and genetics of B. subtilis L-forms
and found key genetic changes associated with the initial
switch from the walled to the L-form state (Domı´nguez-Cuevas
et al., 2012; Kawai et al., 2015; Leaver et al., 2009; Mercier
et al., 2013). Those studies highlight that L-forms do not require
PG synthesis or the FtsZ-based division machine, both of
which are normally essential, for their proliferation (Adams
and Errington, 2009). Instead, L-form proliferation is brought
about by an increased rate of membrane synthesis, leading
to an increased membrane surface area to volume ratio, which
drives cell shape deformations that lead to spontaneous scis-
sion (Mercier et al., 2013). The excess membrane synthesis
can be generated by directly activating the fatty acid mem-
brane synthetic pathway, or indirectly, by shutting down
lipid II precursor pathway, which works via an as yet uncharac-
terized mechanism (Mercier et al., 2013). Antibiotics that block
lipid II precursor synthesis, such as fosfomycin and D-cyclo-
serine, also rapidly and efficiently induce the L-form switch in
a wide range of bacteria, including the pathogenic Firmicute
Staphylococcus aureus, under laboratory conditions (Mercier
et al., 2014).
Historically, b-lactam antibiotic treatments have been used to
promote the L-form state in osmotically supportive medium
(e.g., in the presence of sucrose) in many laboratories; however,
this is usually a tedious process with a low success rate andublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. PenG Prevents the L-Form Switch
from the Walled State
(A) Schematic representation of peptidoglycan (PG)
synthesis in B. subtilis and its inhibition by antibi-
otics. The PG wall is built from long glycan strands
composed of N-acetylmuramic acid (MurNAc) and
N-acetylglucosamine (GlcNAc) crosslinked to each
other by short peptide bridges. The precursor for PG
is initially synthesized in the cytoplasm by the action
of MurAA, MurAB, MurC, MurD, MurE, and MurF
enzymes. MurNAc-pentapeptide is coupled to a
membrane carrier, undecaprenyl pyrophosphate,
by MraY, and GlcNAc is added by MurG to form
lipid II, which is then transferred to the outside
of the cytoplasmic membrane. Newly synthesized
PG is incorporated into the existing PG meshwork
by a combination of transglycosylation and trans-
peptidation reactions catalyzed by penicillin-bind-
ing proteins (PBPs) and RodA. The antibiotics
fosfomycin and D-cycloserine inhibits MurA and
Ddl, respectively. The b-lactam antibiotics including
penicillins (e.g., penicillin G) and cephalosporins
(e.g., cephalexin) target the PBPs.
(B–D) Effects of antibiotics on L-form switch. (B)
B. subtilis strains wild-type (168CA) and ispA
mutant (RM81) were grown on NA/MSM plates with
or without 200 mg/mL D-cycloserine (DCS) (with
1 mg/mL of FtsZ inhibitor 8j to prevent the rare
reversion to walled cells) or 200 mg/mL penicillin G
(PenG) at 30C for 2–3 days. (C) PC micrographs of
ispA mutant cells with or without DCS taken from
the cultures shown in (B). (D)B. subtilis L-form strain
(LR2; Pxyl-murE ispA
) was grown on NA/MSM
plates with or without PenG in the absence of
xylose.
(E–G) Effects of PenG on L-form emergence from
the parental walled cells in LR2 (Pxyl-murE ispA
;
E and F) and RM81 (ispA murE+; G). Individual
frames are extracted from example movies of
time-lapse experiments (see also Movies S1 and
S2). Numbers in the bottom right corner of each
frame represent time (min) elapsed in the movies.
Examples of L-form emergence are shown by blue
arrows.
See also Figures S1 and S2.requires long term and repeated passage (Allan, 1991). In our
early experiments with B. subtilis L-forms, we found that peni-
cillin treatment surprisingly prevents the switch from walled to
L-form states (Leaver et al., 2009). We subsequently started
to characterize the L-form switch in further detail and found
that escape of the protoplast from the enveloping cell wall
was an important intermediate step that could be influenced
by various antibiotics and lysozyme (Domı´nguez-Cuevas
et al., 2012). However, at that time we were unaware of the con-
founding role of oxidative stress in L-form growth (Kawai et al.,
2015). Because we were not tracking the presence/absence of
SNPs that might affect oxidative stress, interpretation of the ef-
fects of other factors on L-form growth was problematical. We
now show that in B. subtilis and a wide range of Gram-positive
bacteria (but not the Gram-negative Escherichia coli), b-lactams
fail to induce efficient L-form switching and that this is likely
because inactivation of class A, bifunctional PBPs results in in-hibition of the autolytic enzymes responsible for escape of the
cell protoplast from the parental walled cell. Crucially, addition
of an exogenous PG hydrolase, such as lysozyme, enables
L-form escape and thereby protects from cell killing by the an-
tibiotics. Using an animal model, Galleria mellonella, we show
that the L-form transition can be initiated in a host environment,
presumably by host lytic enzymes. Finally, we reproduce these
effects in an in vitro mammalian macrophage system and show
that under these conditions macrophages can actually protect
input walled cells from penicillin killing. The results have impor-
tant implications for our understanding of b-lactam antibiotic
activity under physiologically relevant conditions, especially
for how bacteria can evade antibiotic action utilizing innate im-
mune effectors of host cells. They also stress that the killing
effects of antibiotics can vary dramatically depending on the
culture conditions, including the level of osmoprotection and
presence of lytic enzymes.Cell 172, 1038–1049, February 22, 2018 1039
RESULTS
PenG Inhibits the Emergence of L-Forms from Parental
Walled Cells
We have previously shown that inhibition of the lipid II pathway
promotes L-form formation and proliferation on isotonic (i.e., suf-
ficiently osmoprotective to support L-form growth) media in a
wide range of bacteria (Mercier et al., 2013, 2014). Bacillus sub-
tilis is presently the best characterized model for L-form biology
(Errington et al., 2016). As shown in Figures 1B and 1C,B. subtilis
cells grew with a typical rod-shaped morphology on isotonic
plates with no antibiotic (No addition). However, when the rods
were streaked on plates with D-cycloserine (DCS), which inhibits
D-alanine-D-alanine ligase in the lipid II pathway (Figure 1A), they
switched to spherical wall-deficient L-forms (Figures 1B and 1C,
DCS). Note that under aerobic conditions, B. subtilis L-form
growth also requires a mutation in a gene such as ispA to avoid
cell lysis due to increased oxidative damage in wall-deficient
cells (Kawai et al., 2015), so all of the experiments with
B. subtilis herein involved strains bearing an ispA mutation. In
contrast, growth was severely impaired when the rods were
streaked on isotonic plates with b-lactam antibiotics penicillin
G (PenG) or cephalexin (Figures 1B, PenG, and S1A, cephalexin),
which inhibit PG assembly (Figure 1A). A few colonies eventually
emerged but only after 3 days or more of incubation.
As reported previously, B. subtilis strain LR2, which carries an
ispAmutation and a repressible Pxyl-murE construct (that allows
control over lipid II synthesis), also undergoes an efficient L-form
switch when lipid II synthesis is repressed under isotonic condi-
tions (Leaver et al., 2009; Mercier et al., 2013) (Figure 1D, no
addition). Once initiated, this L-form mode of proliferation con-
fers complete resistance to most antibiotics acting on PG
biogenesis, including PenG (Leaver et al., 2009; Mercier et al.,
2013). However, the initiation of L-form growth of the LR2 strain
was strongly inhibited in the presence of PenG (Figure 1D,
PenG), suggesting that PenG prevents an earlier step in the tran-
sition from parental walled rods to L-forms.
We developed time-lapse microscopy methods to visualize
the L-form switch from parental rods in the LR2 strain. Figure 1E
and Movie S1 show a typical time course. When lipid II synthesis
was shut down (MurE OFF), walled rods continued to increase in
size and then began to bulge and deform. L-forms then emerged
(blue arrows at 220 and 235 min), which propagated in the clas-
sical manner (involving a range of unusual tubulation and bleb-
bing events generating a heterogeneous mix of cell sizes and
shapes). However, in the presence of PenG (Figure 1F; Movie
S2), even though precursor synthesis was shut down, the char-
acteristic bulging phenotype and L-form emergencewere largely
prevented. Instead, the rods stopped growing and then gradu-
ally became phase-pale (over150min), indicative of cell death.
In passing, it is useful to note that this b-lactam-induced
growth arrest and absence of overt death by explosive lysis (Fig-
ure 1F) is not just seen under osmoprotective conditions, as
here. Figure S2 shows that even under hypotonic conditions,
B. subtilis (and another Gram-positive organism, Staphylo-
coccus aureus) did not change shape significantly for long pe-
riods after PenG treatment. This contrasts with the effects of
these antibiotics on the Gram-negative bacterium Escherichia1040 Cell 172, 1038–1049, February 22, 2018coli, which underwent bulging and dramatic shape changes in
both hypo- and isotonic media (Figure S2; see also below).
These differences between Gram-positive and Gram-negative
bacteria were first noted decades ago (Rodrı´guez-Te´bar et al.,
1982), but this does not seem to have been widely appreciated.
We also note that some of the loss of cell content upon
PenG treatment was likely due to the induction of prophage(s)
by PenG (Figure S1C). Indeed, the rate at which PenG-treated
cells became phase-pale (Figure S1F) or lysed in liquid culture
(Figure S1D) was substantially reduced in a strain from which
prophages have been removed. Prophage induction by b-lactam
action has been described previously for S. aureus (Maiques
et al., 2006). Because prophages are relatively common in
nature, this may be a widespread mechanism of b-lactam killing
that has previously been underappreciated. However, in spite of
this caveat, we found that PenG still blocked L-form emergence
by the MurE OFF condition in the prophage-less background
(Figure S1E); the cells evidently died but without significantly
changing shape (Figure S1F). We do not fully understand the
mechanism of PenG-induced cell death in these experiments,
but it may be due to oxidative stress (Foti et al., 2012; Kawai
et al., 2015; Kohanski et al., 2007). It is probably not due to futile
cycling, as occurs in E. coli (Cho et al., 2014) because it still
occurred in experiments in which the cells were also inhibited
for PG precursor synthesis (Figure 1D). A similar growth arrest
and cell death was also observed in a murE+ background with
PenG (Figure 1G). It appears that inhibition of the PG precursor
pathway not only promotes the L-form mode of proliferation
but also induces the emergence of L-forms from parental walled
rods, whereas PenG severely impairs L-form emergence.
Lytic Activity Is Required for L-Form Emergence
We previously reported that efficient L-form emergence in
B. subtilis requires mutation of a cell wall homeostasis regulator,
walR, which controls the synthesis and activity of various auto-
lytic enzymes (Domı´nguez-Cuevas et al., 2012). Consistent
with the idea that this mutation works through increased auto-
lytic enzyme activity, elimination of the LytE and CwlO endopep-
tidases that are essential for normal growth of B. subtilis (Hashi-
moto et al., 2012) strongly inhibited L-form growth of the LR2
strain on isotonic plates (Figure 2A, no addition, lytE). Time-
lapse microscopy revealed that in the combined absence of
LytE and CwlO, the cells did not bulge and L-forms failed to
emerge (Figure 2D). Instead, the rods stopped growing and
then died without significant shape changes, similar to the ef-
fects of PenG on the L-form switch described above (Figure 1F).
As anticipated from our previous work (Domı´nguez-Cuevas
et al., 2012), the addition of exogenous lysozyme rescued the
L-form growth defect caused by repression of lytE and cwlO
(Figure 2A, lysozyme). Time-lapsemicroscopy showed that lyso-
zyme induced the emergence of small L-forms from rods (Fig-
ure 2E, blue arrows at 200 min; Movie S3) and they propagated
similarly to L-forms in the parental (lytE+, cwlO+) strain (Fig-
ure 1E), supporting the idea of a key role for ongoing autolytic ac-
tivity in L-form emergence induced by inhibition of the lipid II
pathway.
If the failure in L-form emergence caused by PenG was due to
an antibiotic-induced block in the action of cell wall hydrolases,
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Figure 2. PenG Inhibits L-Form Emergence
by Preventing Autolytic Activity
(A) Effects of autolytic activity on L-form growth. B.
subtilis strains YK2288 (lytE+;Pxyl-murE ispA
Pspac-
cwlO) and YK2289 (lytE; Pxyl-murE ispA
 DlytE
Pspac-cwlO) were grown on NA/MSM plates (no
xylose) with or without 0.5mM IPTG, and 100 mg/mL
chicken egg white lysozyme at 30C for 2–3 days.
(B and C) Effects of lysozyme on L-form emergence
in the presence of PenG. (B) B. subtilis strains wild-
type (168CA) and ispA mutant (RM81) were grown
on NA/MSM plates containing 200 mg/mL PenG and
lysozyme (Lys) at 30C for 2–3 days. (C) PC micro-
graphs of ispA mutant cells taken from the cultures
shown in (B).
(D and E) Effects of autolytic enzymes (LytE and
CwlO) on L-form emergence from the parental
walled cells in B. subtilis strain (YK2289; Pxyl-murE
ispA DlytE Pspac-cwlO) in the presence (E) or
absence (D) of 20 mg/mL chicken egg white lyso-
zyme.
(F) Exogenous lysozyme promotes L-form emer-
gence in the presence of PenG in a murE+ back-
ground (strain RM81; ispA).
(G) Nucleoid dynamics during the L-form emer-
gence from the walled cells in B. subtilis strain
YK2294 (ispA amyE::hbsU-gfp) in the presence of
PenG and lysozyme.
Numbers in the bottom right corner of the time-
lapse frames in (D)–(G) represent time (min) elapsed.
Examples of L-form emergence in (E)–(G) are shown
by blue arrows.
See also Figures S1 and S3 and Movies S3 and S4.exogenous lysozyme should also overcome the inhibitory effect
of PenG on L-form emergence. To test this, we streaked an ispA
mutant (wild-type for PG precursor synthesis) on isotonic plates
containing both PenG and lysozyme and found that L-form
growth occurred efficiently even without murE repression (Fig-
ures 2B and 2C). Similar results were obtained by time-lapse mi-
croscopy (Figure 2F; Movie S4): blue arrows at 25 min point to
the emergence of L-forms from rods, which went on to make mi-
cro colonies of typical L-form cells. Addition of lysozyme also
promoted L-form growth in the presence of a different b-lactam
antibiotic, cephalexin (Figures S1A and S1B). Note that although
cephalexin has some specificity for a division-associated trans-
peptidase in many organisms, it nevertheless binds well to the
major class A PBP1 of B. subtilis at sub 1 mg/mL concentration
(Sassine et al., 2017).
The above experiment raised the possibility that lysozyme
alone might be sufficient to establish and maintain L-form
growth. To test this, we made protoplasts (to avoid the need
for the protoplast to escape from the cell wall sacculus) of
B. subtilis and S. aureus, which were then plated in the presence
of lysozyme (or lysostaphin, an endopeptidase that is a more
effective hydrolytic enzyme for S. aureus PG) (Wu et al., 2003),
or PenG (Figure S3; see also below). As expected, robust
L-form growth occurred in the presence of PenG. However, in
the presence of lytic enzyme, most of the cell growth visible ap-peared to be in the walled form (Figure S3B, ‘‘Lysozyme’’), albeit
with a degree of shape distortion and uneven growth. We sug-
gest that because these lytic enzymes do not block de novo
PG synthesis the cells go through continual wall regeneration
and turnover until the lysozyme activity is overwhelmed or
used up. This shows that, in practice, cell wall synthesis needs
to be blocked (either precursor synthesis or assembly) to enable
prolonged L-form growth.
Interestingly, in cells bearing a GFP-fusion to a global DNA
binding protein HbsU, it was possible to visualize nucleoids
passing out of the parent walled cells during L-form emergence
(Figure 2G, blue arrows at 15 and 20 min). Perhaps efficient
L-form emergence requires cell wall lesions large enough to
accommodate exit of the intact nucleoid.
Class A PBPs Are Required for Autolytic Activity during
the L-Form Switch
The above results showed that PenG, which inactivates the
TPase activity of multiple PBPs, triggers an immediate arrest in
cell growth (Figures 1F and 1G). The class A PBPs, of which
B. subtilis has 4, also possess PG glycosyltransferase (GTase)
activity, which is inhibitable by the antibiotic moenomycin
(MOE) (van Heijenoort et al., 1987) (Figure 1A). Figure 3A shows
that MOE had a similar effect to PenG, in rapidly arresting
growth with no significant shape change, and abolished L-formCell 172, 1038–1049, February 22, 2018 1041
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Figure 3. Absence of Class A PBPs Inhibits
the L-Form Switch
(A and B) Effects of moenomycin on the L-form
switch in B. subtilis. (A) B. subtilis strain RM81
(ispA) were grown in NB/MSM with or without
50 mg/mL moenomycin (MOE) at 30C for 2–3 hr
without shaking. (B) B. subtilis L-form strain (LR2;
Pxyl-murE ispA
) was grown on NA/MSM plates
with or without 200 mg/mL PenG or 50 mg/mLMOE
in the absence of xylose at 30C for 2–3 days.
(C and D) Effects of class A PBPs on L-form switch
inB. subtilis. (C) B. subtilis strain RM81 (ispA) and
YK2344 (D4 ispA) were grown on NB/MSM with
or without 200 mg/mL D-cycloserine (DCS) in the
presence or absence of 100 mg/mL lysozyme (Lys)
at 30C for 2–3 days. PC micrograph image of
B. subtilis L-forms of YK2344 (right) was taken
from the plate with D-cycloserine and lysozyme
(DCS/Lys). (D) B. subtilis strain RM81 (ispA) and
YK2344 (D4 ispA) were grown in NB/MSMwith or
without 100 mg/mL PenG and/or D-cycloserine
(DCS) at 30C for 3–4 hr without shaking.
(E) Effects of RodA on L-form switch in B. subtilis.
B. subtilis strain YK1354 (DrodA Pxyl-murE ispA
)
was grown on NA/MSM plates in the presence or
absence of 1% xylose at 30C for 2–3 days. PC
micrographs of B. subtilis cells were taken from
the plates.
See also Figure S2.generation (Figure 3B). Similarly, a mutant deleted for all four
genes encoding class A PBPs (ponA, pbpD, pbpF, and pbpG;
‘‘D4’’ mutant) was severely inhibited for L-form switching by
DCS (Figure 3C, DCS). Again, this inhibition was efficiently
reversed by the addition of lysozyme (Figure 3C, DCS/Lys).
Microscopic examination of cells treated with DCS revealed
that theD4mutant did not expand or bulge (Figure 3D,D4 ispA,
DCS), similar to the control strain treated with PenG (Figure 3D,
ispA, PenG/DCS). Thus, class A PBPs are required, directly or
indirectly, for the cell wall hydrolytic activity that enables bulging
and the L-form switch.
Recently, it was discovered that RodA, a central component of
the MreB-dependent cell elongation complex, also has GTase
activity, and this may be the major GTase required for cell
morphogenesis (Cho et al., 2016; Emami et al., 2017; Meeske
et al., 2016). However, deletion of RodA had no discernable ef-
fect on the L-form transition (Figure 3E), suggesting that the
arrest of autolytic activity by b-lactams is a specific effect of
inhibition of the class A PBP PG synthesis pathway.
Lysozyme Counteracts PenG under Osmoprotective
Conditions in Various Gram-Positive Bacteria
We previously reported that blocking the PG precursor pathway
by fosfomycin or D-cycloserine, which inhibit the MurA or Ddl
proteins, respectively (Figure 1A), promotes efficient L-form
growth in at least two other Gram-positive organisms, the path-
ogenic Firmicute S. aureus and the Actinobacterium Corynebac-
terium glutamicum (Mercier et al., 2014). However, again, the
L-form switch did not occur with PenG (Figures 4 and S4). Fig-
ures S4E and S4F show that these findings hold also for another
pathogenic Firmicute, Enterococcus faecium. Furthermore, for1042 Cell 172, 1038–1049, February 22, 2018all of these organisms, exposure to an exogenous PG hydrolytic
enzyme again promoted L-form growth in the presence of PenG
(Figures 4 and S4), as shown above for B. subtilis. Although
growth of S. aureus L-forms was slightly slower than for
B. subtilis, L-form colonies emerged within 2 days of incubation
on isotonic plates with PenG (or cephalexin) and lysostaphin
(Figures 4A, 4B, S4A, and S4B). Time-lapse microscopy showed
that PenG blocked the proliferation of S. aureus walled cells
(Figures 4C and 4D; Movie S5). However, in the presence of
lysostaphin, the cells became pale in phase contrast images,
presumably due to cell wall degradation (Figure 4E; Movie S6).
The cells then started to grow and change shape, initiating a
typical mode of L-form proliferation. Note that time-lapse imag-
ing with S. aureus is challenging because the L-forms preferen-
tially grow inside the agar or agarose, as described by Han et al.
(2014). Time-lapse microscopy of C. glutamicum again showed
growth arrest with PenG and the emergence of small L-forms
from the parental walled cells and proliferation in a typical
L-form manner on addition of lysozyme (Movie S7).
Contrasting Effects of b-Lactams on Gram-Negative
Bacteria
To test whether these observations held also for Gram-negative
bacteria, we examined the effects of antibiotics affecting PGpre-
cursor synthesis (fosfomycin) or assembly (b-lactams) on E. coli
under isotonic conditions (Figures S5A and S5B). In contrast to
the Gram-positives, treatments with b-lactams did not inhibit
L-form growth induced by fosfomycin (Figures S5A and S5B).
Note that the E. coli experiments were carried out under anaer-
obic conditions because this generates much more robust
L-form growth, as described previously (Kawai et al., 2015).
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Figure 4. Exogenous PG Hydrolase Pro-
motes S. aureus L-Form Switch
(A) Effects of PenG and lysostaphin on L-form
emergence in S. aureus. S. aureus strain (RN4220)
were grown on NA/MSM plates with or without
200 mg/mL PenG and 2 mg/mL lysostaphin at 30C
for 2–3 days.
(B) PC micrographs of S. aureus cells in the pres-
ence or absence of PenG and lysostaphin taken
from the cultures shown in (A).
(C–E) Effects of lysostaphin on L-form emergence
in the presence of PenG. Exponentially growing
S. aureuswalled cells were placed on NA/MSMwith
PenG (D), both PenG and lysostaphin (E), or without
supplements (C) for time-lapse microscopy. Indi-
vidual frames are extracted fromMovies S5 and S6.
Numbers in the bottom right corner of each frame
represent time (min) elapsed in the movies. Note
that the walled S. aureus cells pile on top of each
other in microcolonies so that the individual cells
can become blurred (C). However, in contrast to
L-forms (E) the walled cells retain their small uniform
shape.
See also Figures S3, S4, and S5 and Movie S7.Figures S5C and S5D show that anaerobic conditions made no
difference to our findings for B. subtilis and indeed, as shown
previously, the anaerobic conditions enabled L-form growth in
ispA+ cells. Consistent with a lack of the b-lactam-induced inhi-
bition in L-form growth, treatment with a b-lactam resulted in
dramatic shape changes, predominantly bulging, and culmi-
nated with most cells lysing (Figure S5E, PenG). Treatment
with fosfomycin, as we reported previously, led to a gradual
and fairly regular rounding and eventually to the L-form state
(Figure S5E, FOS). Crucially, when fosfomycin and b-lactam
treatments were combined, the cells took on the regular rounded
and stable appearance of fosfomycin-treated cells (Figure S5E,
PenG/FOS) rather than following the lethal b-lactam pathway.
These results are in principle consistent with the findings of
Cho et al. (2014) in which b-lactams were shown to kill, at least
in part, by a futile cycle of PG precursor synthesis and turnover,
which can be blocked by inhibition of PG precursor synthesis.
Promotion of L-FormSwitching by theHost Environment
Lysozyme, which is highly conserved throughout the animal
kingdom, contributes importantly to innate immune defense
against bacteria. It is present in body secretions including tears,
mucus, saliva, and milk, and cells of the innate immune system
such as macrophages and polymorphonuclear neutrophils pro-
duce large amounts of lysozyme (Ragland and Criss, 2017).CSeveral old reports suggested that expo-
sure of bacteria to macrophages may
contribute to the induction of L-forms
in vivo (Domingue and Woody, 1997). To
test this, we challenged larvae of the wax
moth (Galleria mellonella), an increasingly
widely used simple animal model, which
possesses an innate immune system con-
taining phagocytic cells analogous to hu-man macrophages (Tsai et al., 2016), with B. subtilis and
S. aureus strains tagged with fluorescent fusions. After 3-hr
exposure to walled bacteria, larvae were sacrificed and their he-
molymph was subjected to fluorescence microscopy. Bacterial
cells were observed associated with larval phagocytes (Figures
5A and 5B). Many of the B. subtilis cells were rod-shaped indi-
cating that they retained an intact cell wall (Figure 5A). Addition
of PenG induced a rapid cell lysis for those rods (Figure 5C),
similar to the effects of PenG shown above (Figure 1G). We
also observed many spherical B. subtilis cells, both associated
with the hemocytes and suspended in the hemolymph (Figure 5A,
arrows), which were probably generated due to the action of lytic
enzymes produced by the larvae (Mak et al., 2010). To test their
ability to grow in the L-form state, we plated the hemolymph on
isotonic agar containing PenG. As expected, we observed abun-
dant L-form colonies after 2 days of incubation (Figures 5D and
5E, B. subtilis). Close-ups of examples of the colonies revealed
the typical ‘‘fried-egg’’ L-form colony morphology (Figure 5D, i).
Similar results were obtained with S. aureus (Figures 5D and 5F,
S. aureus). No colonies had appeared after 2 days for a control
hemolymph incubated identically but without bacterial infection
(Figure 5D, left panel). On the basis of these results, it appears
that immune effectors in the host environment, presumably
including lysozyme, can drive an L-form transition that could
contribute to b-lactam tolerance.ell 172, 1038–1049, February 22, 2018 1043
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Figure 5. L-Form Switch Is Induced in Host Environment
(A and B) L-form induction in the G. mellonella larvae. PC micrographs and the corresponding fluorescent images of hemocytes extracted from theG. mellonella
larvae infected for 3 hr with walled B. subtilis (strain YK2267; ispA aprE::mCherry) (A) and S. aureus (strain YK2310; RN4220 pYFP) (B). Examples of spherical
B. subtilis cells are shown by the red arrows in (A).
(C) Effects of PenG on walled B. subtilis in the larvae hemolymph on osmoprotective medium (NA/MSM). Numbers in the bottom right corner of each frame
represent time (min) elapsed in an example movie from time-lapse experiments.
(D and E) The larval hemolymph samples with (middle, B. subtilis; right, S. aureus) or without bacterial infection (left) were placed on NA/MSM plates containing
200 mg/mL PenG and incubated at 30C for 2–3 days. Examples of L-form colony morphologies are shown in i (B. subtilis) and ii (S. aureus).
(E) PC micrographs and the corresponding fluorescence images of B. subtilis (left), and S. aureus (right) L-forms were taken from the plates shown in (D).Mammalian Macrophages Induce L-Form Switching
To test for L-form induction in mammalian phagocytic cells, we
challenged murine macrophage-like RAW-blue cells with walled
cells of a B. subtilis strain that was tagged with mCherry. After
overnight incubation, we observed a significant degree of activa-
tion of the macrophages, as judged by the formation of pseudo-
podia and phagocytic vacuoles (Figure 6A). ManyB. subtilis cells
had been phagocytosed: some were rod-shaped indicating that
they retained an intact cell wall (Figure 6A, arrow). However,
many of the B. subtilis cells had a spherical morphology in mac-1044 Cell 172, 1038–1049, February 22, 2018rophages (Figure 6B), presumably due to the action of lytic en-
zyme(s) made by the macrophages (the negligible signal in the
GFP channel shows that the mCherry signal was specific).
Spherical B. subtilis cells were also seen outside the macro-
phages (presumably due to secreted lytic activity) (data not
shown). The culture was transferred for time-lapse microscopy
onto isotonic agar with PenG, which should support L-form
growth but was detrimental to the macrophages. Figure 6C
andMovie S8 show a typical example of the time-lapse imaging.
Remarkably, B. subtilis cells were able to escape from the dead
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Figure 6. Macrophages Promote an L-Form Switch
(A and B) Macrophage activation by interaction with B. subtiliswalled cells. (A) The left panel shows a typical image of murine macrophage-like RAW-Blue cells in
DMEM medium. After overnight interaction with B. subtilis walled cells (strain YK2267; ispA aprE::mCherry), the activated macrophages were greatly enlarged
and formed pseudopodia and phagocytic vacuoles (right panel). An example of a rod-shaped B. subtilis cell inside a vacuole is shown by the arrow. (B) PC
micrograph of sphericalB. subtilis cells inside the vacuoles (left). Themiddle panel shows the correspondingmCherry image, and the right panel is aGFP image to
demonstrate that fluorescence is specific to the mCherry.
(C–E) Effects of macrophages on L-form growth. (C) The overnight mixed culture of murine macrophages and B. subtilis cells in DMEMmacrophage medium (no
PenG) was placed on a NA/MSM micro-well dish with 200 mg/mL PenG, and incubated at 30C for several hours before time-lapse imaging. Individual PC
micrograph frames are extracted fromMovie S8. Numbers in the bottom right corner of each frame represent time (min) elapsed in the movie. The top left (0) and
bottom right (1,100) corner panels shows the corresponding mCherry images. Examples of L-form emergence are shown by arrows. (D) The overnight cultures of
B. subtilis (upper) or S. aureus (lower) cells with (middle, and right for high magnification) or without macrophages (left) were placed on NA/MSM plates with
200 mg/mL PenG, and incubated at 30C for 2–3 days. (E) PC micrographs and the corresponding fluorescent images of B. subtilis (upper) and S. aureus (lower)
L-forms cells were taken from the plates shown in (D) (PenG and Macrophages).
See also Figure S6.
Cell 172, 1038–1049, February 22, 2018 1045
5μm
NA NA/MSM NA/MSMNA
PenG Macrophage Macrophage/PenG
A
B CPenG Macrophage
NA NA/MSM NA/MSM/PenG
Macrophage/PenGD
i
ii
5μm
5μm
i
ii
E
Viable walled cells
Protoplasts L-forms
Dead walled cells
Figure 7. Bacterial Cells Evade Antibiotic
Action of PenG by Interacting with
Macrophages
(A) Schematic representation for effects of macro-
phages on S. aureus survival in the presence of
PenG.
(B–E) Effects of macrophages on S. aureus survival
and L-form growth in the presence of PenG under
tissue culture conditions. (B) The overnight culture
of S. aureus walled cells in DMEM containing
200 mg/mL PenG was plated on NA and NA/MSM
plates and incubated at 30C for 7 days. (C) The
overnight culture of macrophages and S. aureus
walled cells in DMEM (no PenG) was plated on NA
and NA/MSM plates, and incubated at 30C. PC
micrograph of S. aureus walled cells (right) was
taken from the NA/MSM plate (middle). (D) The
overnight culture of macrophages and S. aureus
walled cells in DMEM with PenG (preceded by 5 hr
incubation without PenG) was plated on NA,
NA/MSM, and NA/MSM with PenG plates and
incubated at 30C. (E) PC micrographs of S. aureus
L-forms (i) and walled cells (ii) were taken from the
NA/MSM plate shown in (D) (middle). We confirmed
walled or L-form state by streaking on hypotonic
plates on which only walled cells grow.macrophage and propagate in a typical L-form manner, as
described above. We plated the mixed culture of murine macro-
phages and B. subtilis cells on NA/MSM plates containing PenG
and observed a lawn of small colonies, which emerged within
2 days (Figures 6D and 6E, B. subtilis). These colonies had a
typical L-form colony morphology in close up (Figure 6D, right).
No colonies had appeared after 2 days for a control bacterial cul-
ture incubated identically but without macrophages (Figure 6D,
left). We repeated the macrophage experiments with S. aureus
tagged with YFP, and the results were similar to those for
B. subtilis (Figures 6D and 6E, S. aureus). These results strongly
support the idea that immune effectors, such as lysozyme, pro-
duced by macrophages, can induce L-form switching of both
B. subtilis and S. aureus, which then bypasses the antibacterial
activity of PenG.
Macrophages Can Protect Bacteria from b-Lactam
Killing
Given the above results, we wondered whether macrophages
could actually protect bacterial cells from PenG action in tissue
culture conditions. We challenged macrophages with S. aureus
walled cells and incubated for 5 hr, followed by the addition of
PenG to the culture. After 24 hr incubation in the presence of
PenG, the culture was plated on various media and colony for-
mation was monitored for 7 days. In a control culture incubated
without macrophages (Figure 7A, left), no colonies had appeared
on either isotonic or hypotonic NA plates (Figure 7B), indicating
efficient cell killing by PenG and no generation of L-forms. In
the culture with macrophages but without PenG (Figure 7A, mid-1046 Cell 172, 1038–1049, February 22, 2018dle), abundant walled cell colonies were
observed on both hypotonic and isotonic
plates (Figure 7C). In contrast, for the cul-ture with both macrophages and PenG (Figure 7A, right), many
small L-form colonies started to appear on isotonic plates after
2–3 days (Figures 7D, middle, and 7E, i) but not on hypotonic
plates (Figure 7D, left). The longer incubation also promoted
the emergence of a few larger colonies on isotonic plates (Fig-
ure 7D, ii), which appeared to contain walled cells (Figure 7E, ii)
and indeed were able to grow on hypotonic medium. Because
L-forms are known to be able to regenerate cell wall in the
absence of selection pressure such as PenG (Kawai et al.,
2014), they probably represent L-forms that had reverted to
the walled state. Indeed, we did not detect large colonies on
isotonic plates containing PenG (Figure 7D, right). These results
showed that interaction with macrophages can protect bacterial
cells from b-lactam killing, apparently by promoting an L-form
switch.
The L-Form Switch Is Driven by Host Lysozyme and
Possibly Other Lytic Factors
To confirm that macrophage-derived lysozyme was contributing
to the apparent L-form switch, we made extracts from cultures
of macrophages and from a lysozyme-non-producing cell type,
human embryonic kidney (HEK) cells, and tested them for pro-
duction of lysozyme by western blotting and ability to cause
rounding of B. subtilis walled cells. As shown in Figures S6A
and S6B, lysozyme was readily detected in macrophage extract
but not in HEK cell extract. Macrophage extract (but not signifi-
cantly HEK cell extract) also caused rounding of B. subtilis cells
and crucially, this was greatly reduced by the presence of a spe-
cific inhibitor of lysozyme, N,N0,N00-triacetylchitotriose (NNNT)
(Ragland and Criss, 2017) (Figures S6C and S6D). As a control,
we showed that purified lysozyme also generated rounding of
B. subtilis cells, and in this case, inhibition by NNNT was com-
plete. It seems possible that the residual rounding activity by
macrophage and HEK extracts in the presence of NNNT is due
to one or more alternative lytic factors, such as PGLYRP2 (Dziar-
ski and Gupta, 2017).
DISCUSSION
Contrasting Effects of PG Precursor and Assembly
Inhibitors
Wepreviously showed that the inhibition of PGprecursor synthe-
sis (e.g., by fosfomycin [FOS] or D-cycloserine [DCS]) promotes
awalled to L-form transition in a wide range of bacteria, including
various Gram-positives and amodel Gram-negative (E. coli), and
representing both free living and pathogenic bacteria (Mercier
et al., 2013, 2014). It is striking (Figures 1E, 3D, and S5E) that
treatment with FOS or DCS, which should block precursor syn-
thesis rapidly and completely, is followed by continued expan-
sion of the cells, leading to bulging and then L-form escape.
Unless inhibition is incomplete, which seems unlikely given the
high doses of inhibitor, or the precursor pools are unexpectedly
large, this expansionmust be due to unchecked autolytic activity
in the existing cell wall. In contrast to this effect, treatment with
b-lactams generally results in an immediate arrest in growth
and only limited shape changes, with no L-form release, for all
of the Gram-positives tested (Figures 1F, 1G, 4D, and S4) (but
not E. coli; see below). Therefore, inhibition of PG synthesis at
the assembly level presumably also blocks autolytic activity,
and hence L-form release. The rescue of L-form growth by lyso-
zyme provides strong support for this view.
b-lactams have many target TPases in the cell. Among these,
the class A PBPs also have GTase activity, which is needed,
together with TPase activity, to synthesize PG. Recent exciting
reports have revealed that the widely conserved RodA protein
(and probably the wider family of SEDS proteins to which it
belongs) also has GTase activity, and this protein is essential
for the elongation of rod-shaped cells, working in conjunction
with the MreB cytoskeleton and specific class B (monofunc-
tional TPase) PBPs (Cho et al., 2016; Emami et al., 2017;
Meeske et al., 2016). It is not yet clear why rod-shaped bacteria
have two distinct major PG synthetic systems, but our results
show clearly that b-lactam inhibition of autolytic activity occurs
through the class A PBP pathway. Thus, MOE, a specific inhib-
itor of the GTase of class A PBPs elicits effects similar to those
of b-lactams, as does deletion of the 4 class A PBP genes,
whereas deletion of rodA does not block, but rather promotes
cell bulging (Figure 3E). Although it is not yet clear how class
A PBP and autolytic activities are coupled, our results provide
interesting new insights into the differential roles of the two
PG synthetic systems.
Different Responses of Gram-Positive and Gram-
Negative Bacteria
The distinction between the responses of Gram-negative and
Gram-positive bacteria to b-lactam treatment were first pointed
out long ago (Rodrı´guez-Te´bar et al., 1982). However, themolec-ular basis for these differences are still not well understood. Both
classes of organism respond similarly to inhibition of precursor
synthesis, in undergoing bulging and under appropriate condi-
tions, L-form growth (Mercier et al., 2014 and above). Bulging
and shape changes were also evident for E. coli treated with
b-lactams, presumably due to ongoing autolytic activity, but
despite these morphological changes, L-form growth did not
occur and the cells died (Figure S5). Although other explanations
are possible, such as oxidative stress, it is not clear why this
would not also occur for precursor synthesis inhibitors. Recent
work from Cho et al. (2014) has shown that a futile cycle of
lipid II synthesis and turnover can contribute to b-lactam-
induced cell death in E. coli. This would be consistent with our
observation that inhibition of precursor synthesis by FOS pro-
tected cells from b-lactam-induced cell death (Figure S5). This
result was again strikingly different from, indeed the reverse of,
the response of the Gram-positive bacteria, in which the b-lac-
tam ‘‘trumped’’ the precursor inhibitor (DCS) (e.g., Figure 1).
However, it is pertinent to note that other Gram-negative patho-
gens, including Vibrio cholera, have been reported to respond to
b-lactam antibiotics by switching to a rounded stable form
(although not a proliferating L-form state), requiring continued
cell wall hydrolase activity (Do¨rr et al., 2015). Clearly, further
work will be needed to understand the general principles of
how b-lactams impact on L-form switching and maintenance in
Gram-negative bacteria.
Host Lytic Enzymes Can Promote the L-Form Switch
Asmentioned above, the notion that the b-lactam effect in Gram-
positive bacteria is due to a block in autolytic activity is strongly
endorsed by the fact that exogenous lysozyme can rescue
L-form generation. There are many potential sources of lytic en-
zymes in nature. We have shown that macrophages and the
hemolymph of G. mellonella, at least, contain molecules that
can bypass the PenG-block to the L-form switch. We showed
directly that the macrophage samples contained lysozyme (Fig-
ure S6), consistent with expectation (Ragland and Criss, 2017)
and this probably contributes much of the lytic activity needed
for the L-form switch. However, the residual activity seen in the
presence of a specific inhibitor of lysozyme points to the pres-
ence of other lytic factors. PGLYRP2 protein has previously
been identified as an innate immune effector with PG amidase
activity, but immune cells are thought to make a plethora of
different effector molecules, either constitutively or in response
to infection (Dziarski andGupta, 2017). Thus,more work on char-
acterizing their specific enzymatic activities on bacterial compo-
nents would seem warranted. Whatever the specific mecha-
nisms involved, it seems remarkable that macrophages can be
protective in b-lactam challenge experiments.
Cell Wall-Deficient Bacteria in Macrophages Can Retain
Viability
Given the battery of innate immune weapons that immune cells
can elaborate, including ROS, antimicrobial peptides, acidifi-
cation, and hydrolytic enzymes, it is generally assumed that,
with the exception of ‘‘professional’’ intracellular pathogens
such as Listeria or Shigella, most bacteria phagocytosed
by macrophages will be killed. However, our results showCell 172, 1038–1049, February 22, 2018 1047
definitively that bacterial cells that have been damaged and
are morphologically aberrant can nevertheless retain viability
and grow if conditions are suitable. We have seen this survival
both in a macrophage cell line and in the hemolymph of
G. mellonella, including bacteria engulfed by phagocytic cells
(Figures 5 and 6). It therefore seems likely that the switch
into a viable L-form-like state will occur at a significant fre-
quency whenever Gram-positive bacteria encounter phago-
cytic cells or environments containing lytic enzymes, and
crucially, this morphological transition does not necessarily
signify bacterial cell death. It remains to be determined how
long cell wall-deficient bacteria can survive inside the phago-
cytic cells (or other in vivo niches) and what are the character-
istics of the individual phagocytes that would allow long-term
persistence of L-forms.
Implications for Persistent or Recurrent Infection
L-forms are completely resistant to b-lactam antibiotics, and
thus, the L-form switch could help bacteria to survive exposure
to antibiotics in infected humans. There is a long history of re-
ports (albeit frequently anecdotal) of the recovery of L-forms
from antibiotic-treated patients (Clasener, 1972; Domingue,
2010; Domingue and Woody, 1997; Errington et al., 2016; On-
wuamaegbu et al., 2005). In principle, many tissue locations
are sufficiently osmoprotective to enable the survival of L-forms
in vivo. Crucially, these conditions are not equivalent to the hy-
potonic agar plating methods frequently used to investigate
antibiotic action. Our macrophage experiments showed directly
that the action of these cells can protect Gram-positive bacteria
from killing by high concentrations of PenG under semi-physio-
logical conditions (Figure 7), and it seems highly likely that this
occurs by the conversion of walled bacteria into an L-form
state. If the L-forms avoid innate immune killing, they could sur-
vive prolonged exposure to cell wall-active antibiotics. Several
mechanisms enabling the recurrence of infection have been
described. The most common involve entry of cells, called
persisters, into a dormant, non-growing state (Fisher et al.,
2017; Harms et al., 2016). Many antibiotics fail to kill such
non-growing cells. However, unlike these dormant persisters,
L-forms remain viable and can continue to proliferate in the
presence of antibiotic. At the end of antibiotic treatment,
L-forms can revert to the walled state (Domingue and Woody,
1997; Kawai et al., 2014; Mercier et al., 2014) (Figures 7D and
7E), enabling the cells, in principle, to reinitiate a full blown
infection. Being highly pleomorphic and flexible, L-forms may
also gain advantage and persist by invading tissues and phys-
iological niches that are inaccessible to walled cells. Given the
effectiveness of b-lactam antibiotics in most clinical situations,
it is likely that L-forms become problematical only under certain
circumstances (e.g., in elderly and or immunocompromised in-
dividuals) where treatment failures are not uncommon. Although
much more work is needed to clarify the clinical importance of
L-forms, our results provide important new insights into the
effects of innate immune molecules such as lysozyme on anti-
biotic evasion by bacteria.
Finally, it is ironic that Fleming’s two great antibacterial discov-
eries, lysozyme (Fleming, 1922) and penicillin (Fleming, 1929),
turn out to act antagonistically under certain circumstances.1048 Cell 172, 1038–1049, February 22, 2018STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial Strains and Growth Conditions
The bacterial strains in this study are listed in the Key Resources Table. Nutrient agar (NA, Oxoid) or nutrient broth (NB, Oxoid) were
used for bacterial growth at 30C. Mu¨eller Hinton agar (Sigma-Aldrich) was used for growth of E. faecium. Supplements, 1 mM IPTG
or 1% xylose were added when required. Bacterial L-forms were grown in osmoprotective medium composed of 2x magnesium-
sucrose-maleic acid (MSM) pH7 (40 mM MgCl2, 1 M sucrose, and 40 mM maleic acid) mixed 1:1 with 2x NB or 2x NA at 30
C.
When necessary, antibiotics were added to media at the following concentrations: 1 mg/ml erythromycin, 200 mg/ml D-cycloserine,
200 mg/ml fosfomycin, 200 mg/ml PenG, 100 mg/ml ampicillin, 50 mg/ml MOE, 100 mg/ml cephalexin and/or 1 mg/ml 8J (FtsZ inhibitor)
(Adams et al., 2011). Anaerobic growth condition was maintained using anaerobic atmosphere generation bags (AnaeroGenTM,
Oxoid) in an anaerobic jar for growth on plates. 10 mMNitrate and 0.1% glutamic acid were added forB. subtilis growth under anaer-
obic conditions. For reasons that are not yet clear, the L-form switch induced by PenG and lysozyme worked well on solid or semi
solid agar, but not or less efficient in liquid conditions.
Cell lines
RAW-Blue cells (InvivoGen Cat#raw-sp, RRID:CVCL_X594) are derived from the murine adult male RAW 264.7 macrophages with
chromosomal integration of a secreted embryonic alkaline phosphatase (SEAP) reporter construct inducible by NF-kB and AP-1.
The cell line was authenticated by RT-PCR. Flp-In 293 T-REx cells (Thermo Fisher Cat#R78007, RRID:CVCL_U427) are derived
from human female embryonic kidney cell line HEK293 and are designed for rapid generation of stable cell lines that ensure homo-
geneous expression of protein of interest from a Flp-In expression vector. These cells contain a single stably integrated FRT site at a
transcriptionally active genomic locus. Both cell lines were maintained in Dulbecco’s Modified Eagle’s medium (DMEM, Sigma
Cat#D6429) supplemented with 5% fetal bovine serum (FBS) at 37C and 5% CO2.
Galleria mellonella insect model
Galleria mellonella TrueLarv (Biosystems technology) are healthy, weight and aged defined larvae in the sixth and final instar stage of
development. While at this stage, it is not possible to sex the larvae using external markers. Weighing between 0.18 and 0.35 g each,
the larvae are surface-sterilized and delivered in sterilized pots, minimizing the likelihood of external contaminants. The larvae are
from an inbred colony that does not receive either antimicrobials or growth hormones in its feed. G. mellonella can be kept in their
pots at 15C for up to two weeks after delivery without any requirement for food or water. There is an ongoing genome sequencing
program for the breeding colony, therefore genotype is not specified. The larvae were ordered as needed from the supplier and used
within a week from delivery. Animals were not used for other procedures.
METHOD DETAILS
Construction of IPTG-Inducible cwlO
The first 200300 bp of the cwlO gene containing Shine-Dalgarno sequence was amplified by PCR from genomic DNA of the wild-
type strain 168CA using the primers cwlO-F and cwlO-R (Key Resources Table), then cloned between the EcoRI and BamHI sites of
plasmid pMutin4 (Vagner et al., 1998), creating pM4-Pspac-cwlO. The resulting plasmids were introduced into B. subtilis to generate
YK2288 and YK2289 (Key Resources Table). In those strains, the full-length cwlO gene is expressed from the IPTG-inducible pro-
moter Pspac. DNA manipulations and transformations were carried out using standard methods.
Microscopic Imaging
For snapshot live-cell imaging, cells weremounted onmicroscope slides covered with a thin film of 1% agarose in water, or NB/MSM
for L-forms. Images were acquired with a Sony Cool-Snap HQ2 cooled CCD camera (Roper Scientific) attached to a Zeiss Axiovert
200M, or a Rolera EM-C2 (Q-imaging) camera attached to a Nikon TiE microscope, and analyzed using Metamorph (Molecular De-
vices). For time lapse imaging, 300 mL of exponentially growing bacterial cells in NB/MSM or the mixed culture of RAW-Blue mac-
rophages and bacterial cells in Dulbecco’s Modified Eagle’s medium (DMEM) were placed on 35 mm sterile glass bottom microwell
dishes (ibidi GmbH, Munich, Germany), which were pre-coated with 2 mg/ml bovine serum albumin (BSA), and incubated for 5 min.
For the depletion of MurE and/or CwlO, using Pxyl-murE and Pspac-cwlO, exponential cell cultures in NB/MSM with xylose and/or
IPTG at 30C were diluted 10-fold in fresh NB/MSM (without xylose and/or IPTG). After incubation for 2 hr at 30C, the cells
were placed on the microwell dishes. The dishes were centrifuged at 100 g for 2 min using a Beckman Allegra X-12R centrifuge.
Non-adherent cells were removed, and a thin layer of NB/MSM with 0.2% agar bacteriological (Oxoid) was placed on the top of
the dishes. The dishes were placed on the microscope stage at 30C. Images were acquired with a Sony Cool-Snap HQ2 cooledCell 172, 1038–1049.e1–e4, February 22, 2018 e2
CCD camera (Roper Scientific) attached to a Zeiss Axiovert 200M, and analyzed using Metamorph (Molecular Devices). Low magni-
fication images of bacteria interacting with macrophages as well as L-form colonies were obtained using Moitc AE200 inverted
microscope equipped with 20x phase contrast objective and MOTICAM digital camera. Pictures and videos were prepared for pub-
lication using ImageJ (https://imagej.nih.gov/ij) and Adobe Photoshop.
Protoplast preparation
Protoplasts were prepared by adding 100 mg/ml lysozyme (for B. subtilis) or 5 mg/ml lysostaphin (for S. aureus) to exponentially
growing bacterial cultures in NB/MSM (OD600nm of 0.1-0.2) at 37
C, and incubated for 30-60 min.
Bacterial Infection Conditions
RAW-Blue cells were seeded the day before for bacterial infection experiments at 0.5 3 106 cells per ml DMEM 5% FBS medium in
25 cm angled neck flasks (NUNC). The macrophages were challenged at a multiplicity of infection (MOI) 100 with B. subtilis (strain
YK2267; ispA- aprE::mCherry) and S. aureus (strain YK2310; RN4220 pYFP) at MOI 1 (or MOI 5 for experiments in the presence of
PenG) in 5 mL of DMEM medium and incubated overnight at 37C and 5% CO2 together with control flasks containing bacteria
only. Where indicated, PenG at a final concentration of 200 mg/ml was added following 5 h co-incubation without the antibiotic.
Adherent cells were dislodged with a scrapper and 100 ml cells were plated onto NA/MSM containing 200 mg /ml PenG plates, or
used for microscopy experiments.
Galleria mellonella larvae were injected in the left posterior proleg with 10 mL inocula of B. subtilis (strain YK2267; ispA- aprE::
mCherry) or S. aureus (strain YK2310; RN4220 pYFP) containing 8 3 109 CFU/ml using microliter syringe (Hamilton) and incubated
for 3 h at 37C. Following the incubation, larvae that did not show signs onmelanisation were placed in 1.5mLmicrofuge tubes on ice
for 30 min. After this time two posterior segments were removed with surgical scissors and the haemolymph was extracted into
the microfuge tubes. 1 mL of the hemolymph was subjected to microscopy and 20 mL were placed on NA/MSM plates containing
200 mg/ml PenG and incubated for 2 days at 30C.
RAW and HEK lysate preparation
RAW-Blue (RAW) and Flp-In 293 T-Rex (HEK) cells were seeded the day before lysate preparation at 0.53 106 cells per ml DMEM5%
FBS medium in 25 cm angled neck flasks (NUNC). Following overnight incubation the cells were adjusted to 6 3 106 cells in 300 mL
DMEM 5% FBS media containing cOmplete Protease Inhibitor Cocktail (Roche Cat#04693159001) and sonicated on ice using
Sonics Vibra-Cell sonicator (VWR) with 3 bursts of 30 s at 40% amplitude. Following sonication, the samples were cleared by centri-
fugation at 12,000 g for 1 min.
SDS-PAGE
Serial 10-fold dilutions of purified human neutrophil lysozyme (Sigma-Aldrich Cat#L8402) were prepared in sterile water at concen-
trations of 200 mg/ml, 20 mg/ml and 2 mg/ml. Serial dilutions of the lysozyme aswell as RAWandHEK lysates adjusted to 5mg/ml were
fixed with 2x Laemmli Sample Buffer (Bio-Rad Cat#161-0737) containing 150 mM DTT, heated for 5 min at 98C and 10 mL of each
sample were loaded along 5 mL of Precision Plus Protein WesternC molecular weight standard (Biorad Cat#161-0737) onto NuPAGE
4%–12%Bis-Tris midi gel (Invitrogen Cat#WG1402BX10). The samples were resolved by running in 1xMES buffer (Life technologies
Cat#NP0002) at 200 V for 45min using XCell4 SureLockMidi-Cell Electrophoresis System (InvitrogenCat#WR0100). The resolved gel
was stained by Commassie Brilliant Blue or subjected to western blotting.
Western blotting
Samples resolved by SDS-PAGEwere transferred using Turbo Blot system (Bio-Rad Cat#170-4155) onto PVDFmembrane (Bio-Rad
Cat#170-4157) which was then blocked for 1 h in 1x PBS, 2% powder milk (Marvel) and 0.005% Tween 20, followed by overnight
incubation in 1x PBS, 2% powder milk (Marvel) and 0.005% Tween 20 containing 1/5000 dilution of Rabbit monoclonal Anti-Lyso-
zyme antibody (Abcam Cat#ab108508, RRID:AB_10861277). The membrane was washed three times in 1x PBS, 0.005% Tween
20 solution and incubated for 1 h in 1x PBS, 2% powder milk (Marvel) and 0.005% Tween 20 containing 1/5000 dilution of Goat
Anti-Rabbit IgG HRP antibody (Sigma Cat#0545) and 1/10,000 dilution of Precision Protein StrepTactin-HRP conjugate (Bio-Rad
Cat#1610380). The samples were visualized using Pierce ECL Plus western blotting substrate (Thermo Fisher Cat#32132) and
ImageQuant LAS4000 mini biomolecular imager (GE Healthcare Sciences).
Lysozyme inhibition assay
B. subtilis strain YK2267 was grown in 5 mL NA at 37C with shaking for 2h. RAW lysate, HEK lysate or lysozyme at 0.1 mg/ml in
DMEM 5% FBS were mixed 1:1 with NA/MSM in duplicates and incubated for 15 min with or without the lysozyme inhibitor
N,N0,N0 0-Triacetylchitotriose (Sigma Cat#T2144) at a final concentration of 5 mg/ml. Approximately 3 3 108 bacterial cells were
placed in 1.5 mL microfuge tubes in 6 replicas and centrifuged at 12,000 g for 1 min. Supernatant was removed and the cells
were resuspended in 100 mL of the lysates or the lysozyme preincubated with or without the inhibitor, followed by 30 min incubation
at 37C. The cells were subjected to phase contrast microscopy on 1% agarose NB/MSM pad.e3 Cell 172, 1038–1049.e1–e4, February 22, 2018
QUANTIFICATION AND STATISTICAL ANALYSIS
For larvae infection experiments 10 animals were used for each of three repeats (n = 30). For the lysozyme inhibition experiment the
columns represent mean number of round or rod-shaped bacteria of 1000 quantified in 3 experiments (n = 3000) with purified lyso-
zyme and HEK lysate, and mean number of round or rod-shaped bacteria out of 1000 quantified in 5 experiments (n = 5000) for RAW
lysate. Error bars represent standard deviation. Mean was used to estimate the magnitude of an effect and standard deviation to
estimate the distribution of the data. No other methods were used to determine whether the data met assumptions of the statistical
approach.
Definition of precision measures used:
Mean is the number obtained by adding several quantities together and dividing the sum by the number of quantities.
Standard Deviation is the root mean square deviation about the mean.Cell 172, 1038–1049.e1–e4, February 22, 2018 e4
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Figure S1. Effects of Prophages and Lysozyme on b-Lactam Killing in B. subtilis, Related to Figures 1 and 2
(A and B) Effects of Lysozyme on B. subtilis L-form growth in the presence of cephalexin. (A), B. subtilis strains wild-type (168CA) and ispAmutant (RM81) were
grown on NA/MSMplates in the presence of 100 mg/ml cephalexin, with or without 100 mg/ml lysozyme, as indicated, at 30C for 2-3 days. (B), PCmicrographs of
ispA mutant cells taken from the plates in the presence of cephalexin and lysozyme shown in (A).
(C) Disc diffusion assay of aB. subtilis strain [CU267 (Ø105MU3)] carrying lacZ reporter for prophage encoded gene onMSMplates containing X-gal using 0.02 mg
PenG per disc.
(D) Growth profiles of B. subtilis ispAmutant in the presence (strain RM81; blue line) or absence of prophages (strain YK2313; red line) under hypotonic (NB) and
isotonic NB/MSM medium with (red line) or without PenG. B. subtilis strains were grown at 30C without shaking.
(E) Effects of prophages on B. subtilis L-form growth in the presence of PenG. B. subtilis L-form strains (LR2; Pxyl-murE ispA
-, and YK2314; Pxyl-murE ispA
-
prophage-) was grown on NA/MSM plates with or without 200 mg/ml PenG in the absence of xylose.
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Figure S2. Effects of Isotonicity on b-Lactam Killing in B. subtilis, S. aureus, and E. coli, Related to Figures 1 and 3
(A) B. subtilis strain RM81 (ispA-) or E. coliwild-type strain BW25113 was grown in hypotonic (NB) or isotonic (NB/MSM)medium with or without 100 mg/ml PenG,
or D-cycloserine (DCS) at 30C for 3-4 hours.
(B and C) Effects of PenG on growth of B. subtilis (RM81, ispA-) or S. aureus (RN4220, wild-type) under hypotonic conditions. (B), Exponentially growing bacterial
cells were placed on NA with 200 mg/ml PenG for time lapse microscopy. Numbers in the top right corner of each frame represent time (min) from time lapse
microscopy. (C), Examples of bacterial cells treated with or without PenG.
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Figure S3. PenG Is Required for L-Form Growth on Osmoprotective Plates, Related to Figures 2 and 4
(A and B) (A), Protoplasts of B. subtilis strain RM81 (ispA-) prepared in NB/MSM with 100 mg/ml lysozyme were plated on NA/MSM with or without 200 mg/ml
lysozyme, or 200 mg/ml PenG, as indicated, and incubated at 30C. (B), PC micrographs of protoplasts prepared in NB/MSM by lysozyme treatment (left), and
cells with or without lysozyme, or PenG were taken from the plates shown in panels (A).
(C and D), (C), Protoplasts of S. aureus wild-type strain (RN4220) prepared in NB/MSM with 5 mg/ml lysostaphin were plated on NA/MSM with or without 5 mg/ml
lysostaphin, or 200 mg/ml PenG, as indicated, and incubated at 30C. (D), PC micrographs of cells with or without lysozyme, or PenG were taken from the plates
shown in panels (C).
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Figure S4. L-Form Switch by Exogenous PG Hydrolase in the Gram-Positive Bacteria, Related to Figure 4
(A and B) Effects of lysostaphin on S. auleus L-form growth in the presence of cephalexin. (A), S. aureus strain (RN4220) was streaked on NA/MSM plates with or
without 100 mg/ml cephalexin, and 2 mg/ml lysostaphin, as indicated, and incubated at 30C for 2-3 days. (B), PC micrographs of cells with lysostaphin and
cephalexin taken from the plates shown in (A).
(C and D) Effects of lysozyme onC. glutamicum L-form growth in the presence of PenG. (C),C. glutamicum strain ATCC13032 was streaked on NA/MSMplates in
the presence (middle and right) or absence of 200 mg/ml PenG, and 100 mg/ml lysozyme, as indicated, and incubated at 30C for 2-3 days. (D), PCmicrographs of
cells taken from the plate shown in (C).
(E and F), E. faecium L-form growth induced by fosfomycin, or PenG and Lysozyme. (E), E. faecium strain ATCC19434 was streaked on Mu¨eller-Hinton/MSM
plates with 200 mg/ml fosfomycin (FOS), 200 mg/ml PenG or PenG and 100 mg/ml lysozyme, or without antibiotics (No addition), and incubated at 30C for
2-3 days. (F), PC micrographs of cells with fosfomycin (middle), PenG and lysozyme (right) or without antibiotics (left) taken from the plates shown in (E).
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Figure S5. Effects of b-Lactam Antibiotics on E. coli L-Form Switch, Related to Figure 4
(A and B) (A), E. coli wild-type strain BW25113 was streaked on NA/MSM plates with (lower panels, FOS) or without 200 mg/ml fosfomycin (upper panels, No), in
the presence of 100 mg/ml ampicillin (middle) or 100 mg/ml cephalexin (right), as indicated, and incubated at 30C for 3 days under anaerobic conditions because
this generates much more robust L-form growth (Kawai et al., 2015). (B), PC micrographs of cells taken from the plates shown in (A, FOS).
(C andD) (C),B. subtiliswild-type strains (168CA) andRM81 (ispA-) were grown onNA/MSMplates with or without 200 mg/ml PenG, and 100 mg/ml lysozyme (Lys),
as indicated, and incubated at 30C for 2-3 days under anaerobic conditions. (D), PC micrographs of cells taken from the plates shown in (D, PenG/Lys).
(E) E. coli wild-type strain BW25113 was grown in NB/MSM liquid with or without 100 mg/ml PenG and/or 100 mg/ml fosfomycin (FOS) at 30C under aerobic
conditions.
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Figure S6. L-Form Switch by Host Lysozyme in Macrophage Extract, Related to Figure 6
(A and B) Visualization of lysozyme in whole cell extracts of macrophage-like RAW-Blue cells by SDS-PAGE and western blot analysis. (A), Coomassie staining of
purified human lysozyme (1, 0.1 and 0.01 mg), and whole cell extracts of RAW-Blue cells (RAW) and human embryonic kidney cells (HEK), as indicated.
M represents molecular weight marker. (B), western blot analysis with monoclonal anti-lysozyme antibody.
(C and D) Effects of lysozyme inhibitor on L-form switch in macrophage extract. (C), Exponentially growing cells of B. subtilis strain RM81 (ispA-) were incubated
with purified human lysozyme (Lysozyme), HEK extract or RAW extract (RAW) in the presence or absence of lysozyme inhibitor (N,N’,N’’-triacetylchitotriose), as
indicated. (D), The relative frequency of L-form switching induced by purified lysozyme (Lysozyme), HEK extract and RAW extract in the presence or absence of
lysozyme inhibitor. The L-form switch was analyzed using similar images to (C). Cells that undergone the switch aremarkedwith purple (L-forms) and cells that did
not undergo the switch are marked in blue (Rods), as indicated. 1000 cells were counted for each experiment. The columns represent the mean of 3 experiments
with purified lysozyme and HEK lysate and average of 5 experiments for RAW lysate. Error bars represent standard deviation.
